» Articles » PMID: 9858519

Type I Interferon-mediated Stimulation of T Cells by CpG DNA

Overview
Journal J Exp Med
Date 1998 Dec 22
PMID 9858519
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

Immunostimulatory DNA and oligodeoxynucleotides containing unmethylated CpG motifs (CpG DNA) are strongly stimulatory for B cells and antigen-presenting cells (APCs). We report here that, as manifested by CD69 and B7-2 upregulation, CpG DNA also induces partial activation of T cells, including naive-phenotype T cells, both in vivo and in vitro. Under in vitro conditions, CpG DNA caused activation of T cells in spleen cell suspensions but failed to stimulate highly purified T cells unless these cells were supplemented with APCs. Three lines of evidence suggested that APC-dependent stimulation of T cells by CpG DNA was mediated by type I interferons (IFN-I). First, T cell activation by CpG DNA was undetectable in IFN-IR-/- mice. Second, in contrast to normal T cells, the failure of purified IFN-IR-/- T cells to respond to CpG DNA could not be overcome by adding normal IFN-IR+ APCs. Third, IFN-I (but not IFN-gamma) caused the same pattern of partial T cell activation as CpG DNA. Significantly, T cell activation by IFN-I was APC independent. Thus, CpG DNA appeared to stimulate T cells by inducing APCs to synthesize IFN-I, which then acted directly on T cells via IFN-IR. Functional studies suggested that activation of T cells by IFN-I was inhibitory. Thus, exposing normal (but not IFN-IR-/-) T cells to CpG DNA in vivo led to reduced T proliferative responses after TCR ligation in vitro.

Citing Articles

The TLR7/9 adaptors TASL and TASL2 mediate IRF5-dependent antiviral responses and autoimmunity in mouse.

Drobek A, Bernaleau L, Delacretaz M, Calderon Copete S, Royer-Chardon C, Longepierre M Nat Commun. 2025; 16(1):967.

PMID: 39856058 PMC: 11759703. DOI: 10.1038/s41467-024-55692-y.


Control of adaptive immunity by pattern recognition receptors.

Carroll S, Pasare C, Barton G Immunity. 2024; 57(4):632-648.

PMID: 38599163 PMC: 11037560. DOI: 10.1016/j.immuni.2024.03.014.


A randomized, double-blind, placebo-controlled phase I trial of inhalation treatment of recombinant TFF2-IFN protein: A multifunctional candidate for the treatment of COVID-19.

Liu Y, Zhai G, Fu W, Zhang X, Xu J Front Pharmacol. 2022; 13:1063106.

PMID: 36578554 PMC: 9790930. DOI: 10.3389/fphar.2022.1063106.


Cytosolic dsRNA improves neonatal innate immune responses to adjuvants in use in pediatric vaccines.

Brennan K, Craven S, Cheung M, Kane D, Noone E, OCallaghan J J Leukoc Biol. 2022; 112(3):523-537.

PMID: 35098572 PMC: 9542317. DOI: 10.1002/JLB.5A0521-242R.


An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell Memory.

Haabeth O, Lohmeyer J, Sallets A, Blake T, Sagiv-Barfi I, Czerwinski D ACS Cent Sci. 2021; 7(7):1191-1204.

PMID: 34341771 PMC: 8265720. DOI: 10.1021/acscentsci.1c00361.


References
1.
Dumont F, Coker L . Interferon-alpha/beta enhances the expression of Ly-6 antigens on T cells in vivo and in vitro. Eur J Immunol. 1986; 16(7):735-40. DOI: 10.1002/eji.1830160704. View

2.
Sun S, Kishimoto H, Sprent J . DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen. J Exp Med. 1998; 187(7):1145-50. PMC: 2212202. DOI: 10.1084/jem.187.7.1145. View

3.
Messina J, Gilkeson G, Pisetsky D . Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J Immunol. 1991; 147(6):1759-64. View

4.
Holan V, Nakamura S, Minowada J . Inhibitory versus stimulatory effects of natural human interferon-alpha on proliferation of lymphocyte subpopulations. Immunology. 1992; 75(1):176-81. PMC: 1384821. View

5.
Tokunaga T, Yano O, Kuramoto E, Kimura Y, Yamamoto T, Kataoka T . Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol Immunol. 1992; 36(1):55-66. DOI: 10.1111/j.1348-0421.1992.tb01642.x. View